We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-12.38%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$16B
AUM Growth
-$3.46B
Cap. Flow
-$518M
Cap. Flow %
-3.24%
Top 10 Hldgs %
25.29%
Holding
1,819
New
100
Increased
562
Reduced
749
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 25.04%
2 Healthcare 18.78%
3 Financials 12.18%
4 Consumer Discretionary 9.78%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVOV icon
1451
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.37B
$21K ﹤0.01%
502
-400
-44% -$22.9K
CZA icon
1452
Invesco Zacks Mid-Cap ETF
CZA
$192M
$20K ﹤0.01%
370
DOL icon
1453
WisdomTree True Developed International Fund
DOL
$845M
$20K ﹤0.01%
550
-760
-58% -$33.6K
IDEV icon
1454
iShares Core MSCI International Developed Markets ETF
IDEV
$32.7B
$20K ﹤0.01%
447
ISCG icon
1455
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.02B
$20K ﹤0.01%
720
RXI icon
1456
iShares Global Consumer Discretionary ETF
RXI
$274M
$20K ﹤0.01%
215
XHS icon
1457
State Street SPDR S&P Health Care Services ETF
XHS
$207M
$20K ﹤0.01%
355
NEOS
1458
DELISTED
Neos Therapeutics, Inc
NEOS
$20K ﹤0.01%
26,900
+10,500
+64% +$14.4K
IBDL
1459
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$20K ﹤0.01%
800
IBDM
1460
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$20K ﹤0.01%
825
FGD icon
1461
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
$19K ﹤0.01%
1,200
FXO icon
1462
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$19K ﹤0.01%
918
+803
+698% +$24K
IHE icon
1463
iShares US Pharmaceuticals ETF
IHE
$1.65B
$19K ﹤0.01%
420
IRIX icon
1464
IRIDEX
IRIX
$15.1M
$19K ﹤0.01%
11,928
PBE icon
1465
Invesco Biotechnology & Genome ETF
PBE
$358M
$19K ﹤0.01%
400
XPH icon
1466
State Street SPDR S&P Pharmaceuticals ETF
XPH
$510M
$19K ﹤0.01%
532
ENFR icon
1467
Alerian Energy Infrastructure ETF
ENFR
$521M
$18K ﹤0.01%
+1,768
New +$30.7K
FCOM icon
1468
Fidelity MSCI Communication Services Index ETF
FCOM
$1.76B
$18K ﹤0.01%
628
INOD icon
1469
Innodata
INOD
$2.01B
$18K ﹤0.01%
22,000
JHML icon
1470
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
$18K ﹤0.01%
557
TOVX icon
1471
Theriva Biologics
TOVX
$11M
$18K ﹤0.01%
218
+13
+6% +$1.48K
AOA icon
1472
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
$17K ﹤0.01%
362
+100
+38% +$5.48K
EQAL icon
1473
Invesco Russell 1000 Equal Weight ETF
EQAL
$844M
$17K ﹤0.01%
697
FTSL icon
1474
First Trust Senior Loan Fund ETF
FTSL
$2.33B
$17K ﹤0.01%
400
GSBD icon
1475
Goldman Sachs BDC
GSBD
$1.08B
$17K ﹤0.01%
1,400
+700
+100% +$13.2K

Similar funds

William Blair & Company's Q1 2020 Portfolio in Review

As of Q1 2020, William Blair & Company held 1,819 positions worth $16B, down 18% from $19.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

William Blair & Company withdrew a net $518M in Q1 2020, closing 158 positions and reducing 749 holdings. Its most notable exit was Raytheon Company, an estimated $47.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, William Blair & Company opened a new position in Canoo Inc. Class A Common Stock worth $4.04M.

  • William Blair & Company's largest Q1 2020 buy was Canoo Inc. Class A Common Stock: 870 shares worth $4.04M.
  • William Blair & Company added most to Vanguard FTSE Developed Markets ETF in Q1 2020, an estimated $57.8M increase.
  • William Blair & Company's biggest Q1 2020 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $51.6M.
  • William Blair & Company fully exited Raytheon Company in Q1 2020, selling an estimated $47.8M.
  • William Blair & Company's ten largest holdings make up 25% of its $16B portfolio in Q1 2020.
  • William Blair & Company opened 100 new positions and closed 158 in Q1 2020.
  • William Blair & Company's portfolio value fell 18% quarter-over-quarter to $16B.

Based on William Blair & Company's 13F filing for Q1 2020, filed 11 May 2020.